Pathophysiological mechanisms and treatment of red blood cell abnormalities
Multi-user equipment approved in grant 19/18886-1: PeriCam PSI NR
Genomic editing with CRISPR/Cas9 for production of hereditary persistance of fetal...
Evaluation of the efficacy and safety of a strategy based on gene therapy with a v...
Multiplex CRISPR/Cas9 genome editing using ribonucleoprotein complexes for the gen...
Adenine base editing (ABE) to correct pathogenic variants in hematopoietic stem ce...
Fetal hemoglobin induction as a treatment strategy for sickle cell anemia using ge...